Epigenetics in Cystic Fibrosis: Epigenetic Targeting of a Genetic Disease

Related Experiment Video

Updated: Apr 14, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

11.2K

Nualpun Sirinupong, Zhe Yang1

  • 1Department of Biochemistry and Molecular Biology, Wayne State University School of Medicine, 540 East Canfield Street, Detroit, Michigan 48201, USA. zyang@med.wayne.edu.

Current Drug Targets
|April 18, 2015
PubMed

Insights

Epigenetics influences cystic fibrosis transmembrane conductance regulator (CFTR) gene expression, offering potential therapeutic targets. Research is exploring how DNA methylation and histone modifications impact CFTR, though this field is still developing.

Area of Science:

  • Molecular Biology
  • Genetics
  • Epigenetics

Background:

  • Cystic fibrosis (CF) is a genetic disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene.
  • The precise epigenetic mechanisms regulating CFTR expression remain largely unknown.
  • Epigenetics, involving DNA methylation and histone modifications, offers a layer of gene expression control beyond DNA sequence.

Purpose of the Study:

  • To review the current understanding of epigenetic regulation of CFTR transcription.
  • To discuss potential therapeutic strategies targeting epigenetic modifications in CF.

Main Methods:

  • Literature review of epigenetic mechanisms affecting CFTR gene.
  • Analysis of studies on DNA methylation and histone modifications in CFTR regulation.
  • Exploration of epigenetic drug targets such as DNA methyltransferase, histone deacetylase, and histone methyltransferase/demethylase inhibitors.

Main Results:

  • Epigenetic mechanisms, including DNA methylation and histone modifications, play a role in regulating CFTR gene transcription.
  • Reversibility of epigenetic changes makes them attractive therapeutic targets.
  • Current research indicates that epigenetic targeting for CF is in its early stages.

Conclusions:

  • Epigenetic regulation of CFTR presents a promising avenue for novel CF therapies.
  • Further research is needed to fully elucidate these mechanisms and develop effective epigenetic-based treatments for CF.

More Related Videos

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

8.3K
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

20.3K

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
637
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
94
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
70